1-4 of 4
Yanyu Jiang
Close
Sort by
Journal Articles

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Wenyi Lu, MD, Yunxiong Wei, Yaqing Cao, Xia Xiao, MD, Qing Li, Hairong Lyu, Yili Jiang, Huan Zhang, Jia Wang, Xin Li, Yanyu Jiang, Meng Juanxia, Yuan Ting, Haibo Zhu, Xiaoyuan He, Xin Jin, Rui Sun, Tao Sui, Kaiqi Liu, Mingfeng Zhao, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-140431
Published: 2020
Journal Articles

Anti-CD19-CAR T-Cell from Patients Relapsed after Allo-HSCT with a Low Level of Donor Chimerism Restored to Complete Donor Chimerism: Successful Cases and Analysis

Qing Li, Juan Mu, Zhen-xing Yang, Nan Mou, Jia Wang, Ji-jun Yuan, Yanyu Jiang, Meng Juanxia, Qi Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5628.
https://doi.org/10.1182/blood-2019-127850
Published: 2019
Journal Articles

CD19-CAR T Cells Treatment for Minimal Residual Disease in B-Cell Lymphoma with a Higher Response Rate and Fewer Adverse Reactions

Xia Xiao, MD, Yanyu Jiang, Xiaoyuan He, Xin Jin, Cao Yaqing, Sui Tao, Yuan Ting, Mingfeng Zhao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3714.
https://doi.org/10.1182/blood-2018-99-114934
Published: 2018
Journal Articles

ERG11 and ABC2 Overexpression but Not ERG11 Gene Mutations Are Involved in the Development of Itraconazole Resistance in Candida Krusei

Xiaoyuan He, Mingfeng Zhao, MDPhD, Jinyan Chen, Rimao Wu, PhD, Jianlei Zhang, Rui Cui, MDPhD, Yanyu Jiang, Jie Chen, Xiaoli Cao, Yi Xing, Juanxia Meng, Qi Deng, Tao Sui, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4624.
https://doi.org/10.1182/blood.V126.23.4624.4624
Published: 2015